WO2024161314 - CAPPING ASSAY

National phase entry is expected:
Publication Number WO/2024/161314
Publication Date 08.08.2024
International Application No. PCT/IB2024/050863
International Filing Date 31.01.2024
Title **
[English] CAPPING ASSAY
[French] DOSAGE DE COIFFAGE
Applicants **
SEQIRUS INC. 475 Green Oaks Parkway Holly Springs, North Carolina 27540, US
Inventors
QIAN, Jiang c/- Seqirus Inc. 475 Green Oaks Parkway Holly Springs, North Carolina 27540, US
ZHANG, Ying c/- Seqirus Inc. 475 Green Oaks Parkway Holly Springs, North Carolina 27540, US
WANG, Zhichun c/- Seqirus Inc. 475 Green Oaks Parkway Holly Springs, North Carolina 27540, US
CAO, Zhijun c/- Seqirus Inc. 475 Green Oaks Parkway Holly Springs, North Carolina 27540, US
Priority Data
63/482,343   31.01.2023   US
front page image
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing1958
EPO Filing, Examination12543
Japan Filing592
South Korea Filing575
USA Filing, Examination4205
MasterCard Visa

Total: 19873

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] The present disclosure relates to methods for quantifying mRNA capping efficiency. The methods use detectable labels for quantifying the amount of unlabelled mRNA in a sample. The method is applicable to RNA molecules of any sequence and may be used to obtain information on the physical properties of an RNA sample. The present disclosure also relates to kits which can be used for quantifying mRNA capping efficiency.[French] La présente invention concerne des procédés de quantification de l'efficacité de coiffage d'ARNm. Les procédés utilisent des marqueurs détectables pour quantifier la quantité d'ARNm non marqué dans un échantillon. Le procédé est applicable à des molécules d'ARN de n'importe quelle séquence et peut être utilisé pour obtenir des informations sur les propriétés physiques d'un échantillon d'ARN. La présente invention concerne également des kits qui peuvent être utilisés pour quantifier l'efficacité de coiffage d'ARNm.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙